- Argentina
 - Australia
 - Austria
 - Bangladesh
 - Belgium
 - Botswana
 - Brazil
 - Bulgaria
 - Canada
 - Chile
 - China
 - Colombia
 - Cuba
 - Czech Republic
 - Egypt
 - Estonia
 - Ethiopia
 - Finland
 - France
 - Germany
 - Ghana
 - Greece
 - Hong Kong
 - Hungary
 - India
 - Indonesia
 - Ireland
 - Israel
 - Italy
 - Japan
 - Kenya
 - Latvia
 - Lebanon
 - Lithuania
 - Malaysia
 - Mexico
 - Morocco
 - Namibia
 - Netherlands
 - New Zealand
 - Nigeria
 - Norway
 - Pakistan
 - Peru
 - Philippines
 - Poland
 - Portugal
 - Romania
 - Russia
 - Saudi Arabia
 - Senegal
 - Singapore
 - Slovakia
 - Slovenia
 - South Africa
 - South Korea
 - Spain
 - Sweden
 - Switzerland
 - Taiwan
 - Tanzania
 - Thailand
 - Turkey
 - Uganda
 - Ukraine
 - United Arab Emirates
 - United Kingdom
 - United States
 - Venezuela
 - Vietnam
 - Zimbabwe
 
                    Israel Business News API
Get the live top business headlines from Israel with our JSON API.
Get API key for the Israel Business News APIAPI Demonstration
This example demonstrates the HTTP request to make and the JSON response you will receive when you use the news api to get the top headlines from Israel.
                            GET
                        
                    
                        https://gnews.io/api/v4/top-headlines?country=il&category=business&apikey=API_KEY
                    
                {
    "totalArticles": 97060,
    "articles": [
        {
            "id": "a955049217577d5e48c971922bd6d2fb",
            "title": "האקזיטים של עידן ה-AI: מהירים מדליקים וזולים",
            "description": "האינטרסנטים, הפודקאסט הכלכלי היומי של TheMarker- באולפן רותם שטרקמן וסיון קלינגבייל.",
            "content": "האינטרסנטים, הפודקאסט הכלכלי היומי של TheMarker- באולפן רותם שטרקמן וסיון קלינגבייל.\nכמות החדשות ביממה היא של שנה שלמה, אז ננסה לעשות סדר במה שחשוב.\nעל פרשיית הפנסיה וההסתדרות או בשם שיותר נכון לה - פרשיית מרכז הליכוד, יהיו איתנו ירדן בן גל הירשהורן,... [337 chars]",
            "url": "https://www.themarker.com/podcasts/2025-11-04/ty-article-podcast/0000019a-4ecd-d2eb-afda-cecdf24e0000",
            "image": "https://img.haarets.co.il/bs/0000019a-4ecd-d2eb-afda-cecdf24e0000/51/a2/1f01314c407d8a9f9ad6907c138b/1761926940385.jpeg?precrop=1024,596,x0,y114&width=1200&height=630&cmsprod",
            "publishedAt": "2025-11-04T13:27:00Z",
            "lang": "he",
            "source": {
                "id": "f39789b95c8ca38ec5f5edb833d25e85",
                "name": "TheMarker",
                "url": "https://www.themarker.com"
            }
        },
        {
            "id": "58bfa4303f115c383e4698fae553c7c2",
            "title": "Post Hindenburg, Adani Enterprises plans to raise $2.8 billion from rights issue",
            "description": "A report by U.S. short seller Hindenburg derailed Adani Enterprises' plans to raise money in 2023.",
            "content": "Adani Enterprises on Tuesday announced plans to raise 250 billion rupees ($2.8 billion) through a rights issue of shares as it seeks to move on from the controversy that erupted the last time it announced an equity fundraise.\nAdani Enterprises — whic... [1310 chars]",
            "url": "https://www.cnbc.com/2025/11/04/post-hindenburg-adani-enterprises-plans-to-raise-2point8-billion-from-rights-issue.html",
            "image": "https://image.cnbcfm.com/api/v1/image/108070014-17331600242024-12-02t070458z_587775375_rc2rfbajk3cu_rtrmadp_0_adani-group-usa.jpeg?v=1733160050&w=1920&h=1080",
            "publishedAt": "2025-11-04T12:58:21Z",
            "lang": "en",
            "source": {
                "id": "32c2ad3fb41cb87b5b847d750028dff0",
                "name": "CNBC",
                "url": "https://www.cnbc.com"
            }
        },
        {
            "id": "8f8815d24539e78507c110b27342c7be",
            "title": "Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment",
            "description": "Novavax has successfully achieved U.S. BLA approval and completed both EU and U.S. marketing authorization transfers for Nuvaxovid™ to Sanofi in line with its CLA and its corporate strategy,...",
            "content": "Novavax has successfully achieved U.S. BLA approval and completed both EU and U.S. marketing authorization transfers for Nuvaxovid™ to Sanofi in line with its CLA and its corporate strategy, securing a total of $225 million in non-dilutive capital ye... [6923 chars]",
            "url": "https://ir.novavax.com/press-releases/2025-11-04-Novavax-Completes-U-S-Marketing-Authorization-Transfer-to-Sanofi-for-Nuvaxovid-TM-,-Triggering-a-25-Million-Milestone-Payment",
            "image": "https://ir.novavax.com/sites/rebrand/files/images/novavax-social-share.png",
            "publishedAt": "2025-11-04T12:04:04Z",
            "lang": "en",
            "source": {
                "id": "9687567acce7a3a786719ca0709a6382",
                "name": "Novavax Investor Relations",
                "url": "https://ir.novavax.com"
            }
        }
    ]
}